Investigation Report on Chinese Salmeterol/Ticasone Market 2021-2025

Investigation Report on Chinese Salmeterol/Ticasone Market 2021-2025

$2600 – $3900

SKU: 2105488 Category: Tag:

Description

Description
Salmeterol/Ticasone is a compound medication used in regular treatment of asthma and chronic obstructive pulmonary disease (COPD). Its original drug was developed by GlaxoSmithKline. In 2001, Salmeterol Ticasone powder inhalation was approved to enter the Chinese market, and its indication was chronic obstructive pulmonary disease (COPD), and its trade name was SERETIDE; a new indication for asthma was added in China in 2010. SERETIDE powder inhalation has been covered in the category B medical insurance catalogs of 31 provinces, and by 2020 the manufacturers of Salmeterol/Ticasone in China is Glaxo Wellcome(formerly the welcome Foundation) and GlaxoSmithKline(France).

According to CRI’s market research, the sales of Salmeterol/Ticasone have had an increasing trend in the Chinese market from 2016 to 2019.The sales revenue in 2020 was approximately CNY296.77million. However, the sales of Salmeterol/Ticasone in 2020 decreased by 21.59% compared with that in 2019 due to the COVID-19 epidemic. The CAGR for Salmeterol/Ticasone is approximately -3.82% from 2016 to 2020.

According to CRI analysis, from 2021 to 2025, the sales of Salmeterol/Ticasone in China will have a recovery growth with the improvement of the epidemic situation and normal operation of overall diagnosis and treatment in hospitals. After the patent for Salmeterol/Ticasone expired, more biosimilar drugs will appear in the market. In China, Respirent Pharmaceuticals Co. Ltd has already submitted an application for Salmeterol/Ticasone in 2021. Therefore, in the next few years, the market share for Glaxo Wellcome (formerly the wellcome Foundation) and GlaxoSmithKline (France) will gradually shrink. At the same time, with the launch of biosimilar drugs, the price will be further reduced. The price adjustment will reduce the burden on patients, thereby increasing the use and sales of Salmeterol/Ticasone.

Topics Covered:
-The impact of COVID-19 on China’s Salmeterol/Ticasone market
– Sales value of China’s Salmeterol/Ticasone 2016-2020
– Competitive landscape of China’s Salmeterol/Ticasone market
– Prices of Salmeterol/Ticasone in China
– Prices of Salmeterol/Ticasone in China by regions and manufacturers
– Analysis on factors affecting the development of China’s Salmeterol/Ticasone market
– Prospect of China’s Salmeterol/Ticasone market from 2021 to 2025

Additional information

Publisher

Geography Covered

Date Published

Pages

Charts

Format

Base Year

2016
Base Market Size

271.99
Currency/Unit

CNY million
Forecast Year

2025
Market Size Forecast

378.76
CAGR

3.75%

Table of Contents

Table of Contents 1 Relevant Concepts of Salmeterol/Ticasone 1.1 Indications for Salmeterol/Ticasone 1.2 Development of Salmeterol/Ticasone in China 1.3 Governmental Approval of Salmeterol/Ticasone in China 1.4 The Impact of COVID-19 on Salmeterol/Ticasone sales in China 2 Sales of Salmeterol/Ticasone in China, 2016-2020 2.1 Sales Value of Salmeterol/Ticasone 2.1.1 Overall Sales Value 2.1.2 Sales Value by Regions 2.2 Sales Volume of Salmeterol/Ticasone 2.2.1 Overall Sales Volume 2.2.2 Sales Volume by Regions 2.3 Sales of Salmeterol/Ticasone by Dosage Form in China, 2016-2020 2.3.1Gas (powder) aerosol 2.3.2 Analysis of Other Dosage Forms 3 Analysis of Major Salmeterol/Ticasone Manufacturers in China, 2016-2020 3.1 Analysis of Market Share of Major Salmeterol/Ticasone Manufacturers 3.1.1 Investigation on Market Share by Sales Value 3.1.2 Investigation on Market Share by Sales volume 3.2 Glaxo Wellcome (formerly the wellcome Foundation) 3.2.1 Enterprise Profile 3.2.2 Sales of SERETIDE (Glaxo Wellcome (formerly the wellcome Foundation)'s Salmeterol/Ticasone) in China 3.3 GlaxoSmithKline (France) 3.3.1 Enterprise Profile 3.3.2 Sales of SERETIDE (GlaxoSmithKline (France)) in China 4 Prices of Salmeterol/Ticasone for Different Manufacturers in China, 2020-2021 4.1 Glaxo Wellcome (formerly the wellcome Foundation) (SERETIDE) 4.2 GlaxoSmithKline (France) (SERETIDE) 5 Prospect of Chinese Salmeterol/Ticasone drug Market, 2021-2025 5.1 Influential Factors of Chinese Salmeterol/Ticasone Market Development 5.1.1 The Impact of COVID-19 on Chinese Salmeterol/Ticasone Market 5.1.2 Market Drivers and Opportunities 5.1.3 Market Threats and Challenges 5.2 Forecast on Market Size 5.3 Forecast on Market Trend List of Charts Chart Patent Information About Salmeterol/Ticasone Gas (Powder) Aerosol Registration in China Chart Sales Value of Salmeterol/Ticasone Gas (Powder) Aerosol over the World Chart Sales Value of Salmeterol/Ticasone Gas (Powder) Aerosol in China, 2016-2020 Chart Sales Value of Salmeterol/Ticasone Gas (Powder) Aerosol in China by Regions, 2016-2020 Chart Sales Volume of Salmeterol/Ticasone Gas (Powder) Aerosol in China, 2016-2020 Chart Sales Volume of Salmeterol/Ticasone Gas (Powder) Aerosol in China by Regions, 2016-2020 Chart Market Share by Sales Value of Top Salmeterol/Ticasone Manufacturers in China, 2016-2020 Chart Sales Value and Volume of SERETIDE in China, 2016-2020 Chart Referential Prices of SERETIDE in China, 2020-2021 Chart Forecast on Sales Value of Salmeterol/Ticasone Gas (Powder) Aerosol in China, 2021-2025 Chart Forecast on Sales Volume of Salmeterol/Ticasone Gas (Powder) Aerosol in China, 2021-2025

Related products